Baldwin Wealth Partners’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-21,290
| Closed | -$4.19M | – | 400 |
|
|
2024
Q3 | $4.19M | Sell |
21,290
-970
| -4% | -$191K | 0.29% | 64 |
|
|
2024
Q2 | $4.6M | Sell |
22,260
-117
| -0.5% | -$24.2K | 0.36% | 60 |
|
|
2024
Q1 | $6.06M | Buy |
22,377
+22,266
| +20,059% | +$6.03M | 0.46% | 57 |
|
|
2023
Q4 | $26.2K | Sell |
111
-22
| -17% | -$5.2K | ﹤0.01% | 468 |
|
|
2023
Q3 | $26.1K | Hold |
133
| – | – | ﹤0.01% | 478 |
|
|
2023
Q2 | $28K | Hold |
133
| – | – | ﹤0.01% | 494 |
|
|
2023
Q1 | $26.8K | Hold |
133
| – | – | ﹤0.01% | 513 |
|
|
2022
Q4 | $29K | Hold |
133
| – | – | ﹤0.01% | 498 |
|
|
2022
Q3 | $26K | Hold |
133
| – | – | ﹤0.01% | 419 |
|
|
2022
Q2 | $28K | Hold |
133
| – | – | ﹤0.01% | 435 |
|
|
2022
Q1 | $38K | Hold |
133
| – | – | ﹤0.01% | 409 |
|
|
2021
Q4 | $50K | Hold |
133
| – | – | 0.01% | 343 |
|
|
2021
Q3 | $55K | Buy |
+133
| New | +$55K | 0.01% | 334 |
|